Actinium Pharmaceuticals CEO and leadership

Sandesh Seth is Head of Healthcare Investment Banking at Laidlaw & Co. (UK) Ltd., a full-service investment banking and brokerage firm registered with FINRA and the FSA. Laidlaw has institutional and retail distribution through its 100+ member sales force and focuses its investment banking in three domains; healthcare, metals and mining, and social media. In any given year, the firm raises up to $100-$150 million via retail private placements from its high net worth clients. Mr. Seth has 20+ years experience in merchant and investment banking, equity research (Cowen & Co., Bear Stearns, Commonwealth Associates) and in the pharma industry (Pfizer, Warner-Lambert, SmithKline) in strategic planning, business development and R&D project management. Mr. Seth’s financial services experience includes 50+ completed transactions via which $4+ billion in capital was raised. Transactions included venture investments, private placements, IPOs, FOs, PIPEs, Convertible and High-Yield Debt. Mr. Seth was also involved with various strategic initiatives such as mergers and acquisitions, leveraged and management buy-outs, and licensing and joint ventures, including the $100 billion merger of Pfizer and Warner-Lambert and the $20 billion merger of Pharmacia & Upjohn with Monsanto. Mr. Seth has an M.B.A. in Finance from New York University; an M.S. in the Pharmaceutical Sciences from the University of Oklahoma Health Center and a B.Sc. in Chemistry from Bombay University. He has published several scientific articles and was awarded the University Regents Award for Research Excellence at the University of Oklahoma. Mr. Seth was designated as Regulatory Affairs Certified (R.A.C.) by the Regulatory Affairs Professionals Society which signifies proficiency with U.S. FDA regulations.

Steven O'Loughlin is a Principal Financial & Accounting Ofcr at ACTINIUM PHARMACEUTICALS, INC. and Chief Financial Officer/Secretary at ACTINIUM PHARMACEUTICALS, INC. and is based in New York City, New York. He has worked as VP:Corporate Finance & Dev at ACTINIUM PHARMACEUTICALS, INC.; Life Sciences Investment Banking at Forge Financial Group; and Assistant Vice Pres at Jesup & Lamont. Steve attended Ramapo College of New Jersey and CFA Institute.

Sandesh Seth is Head of Healthcare Investment Banking at Laidlaw & Co. (UK) Ltd., a full-service investment banking and brokerage firm registered with FINRA and the FSA. Laidlaw has institutional and retail distribution through its 100+ member sales force and focuses its investment banking in three domains; healthcare, metals and mining, and social media. In any given year, the firm raises up to $100-$150 million via retail private placements from its high net worth clients. Mr. Seth has 20+ years experience in merchant and investment banking, equity research (Cowen & Co., Bear Stearns, Commonwealth Associates) and in the pharma industry (Pfizer, Warner-Lambert, SmithKline) in strategic planning, business development and R&D project management. Mr. Seth’s financial services experience includes 50+ completed transactions via which $4+ billion in capital was raised. Transactions included venture investments, private placements, IPOs, FOs, PIPEs, Convertible and High-Yield Debt. Mr. Seth was also involved with various strategic initiatives such as mergers and acquisitions, leveraged and management buy-outs, and licensing and joint ventures, including the $100 billion merger of Pfizer and Warner-Lambert and the $20 billion merger of Pharmacia & Upjohn with Monsanto. Mr. Seth has an M.B.A. in Finance from New York University; an M.S. in the Pharmaceutical Sciences from the University of Oklahoma Health Center and a B.Sc. in Chemistry from Bombay University. He has published several scientific articles and was awarded the University Regents Award for Research Excellence at the University of Oklahoma. Mr. Seth was designated as Regulatory Affairs Certified (R.A.C.) by the Regulatory Affairs Professionals Society which signifies proficiency with U.S. FDA regulations.